Medical Market Report

Global Transdermal Skin Patch Market By Type (Fentanyl Transdermal Skin Patch, Nicotine Transdermal Skin Patch, Clonidine Transdermal Skin Patch, and Buprenorphine Transdermal Skin Patch), By Application (Relieve Severe Pain, Stop Smoking Cigarettes, Treat An Overactive Bladder, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 137576
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Transdermal Skin Patch Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global transdermal skin patch market is segmented on the basis of Type, Application, and geography.

    The global Transdermal Skin Patch market is estimated to be US$ XX.X Mn in 2019 and is projected to increase significantly at a CAGR of x.x% from 2020 to 2028.

    Transdermal Skin Patch Market Scope:

    By type, the market is segmented into Fentanyl Transdermal Skin Patch, Nicotine Transdermal Skin Patch, Clonidine Transdermal Skin Patch, and Buprenorphine Transdermal Skin Patch. By Application, the market is divided into Relieve Severe Pain, Stop Smoking Cigarettes, Treat An Overactive Bladder, and Others.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Luye Pharma Group Ltd., Purdue Pharma L.P., and Teva Pharmaceutical Industries Ltd..

    Key Market Segments

    Type

    Fentanyl Transdermal Skin Patch

    Nicotine Transdermal Skin Patch

    Clonidine Transdermal Skin Patch

    Buprenorphine Transdermal Skin Patch

    Application

    Relieve Severe Pain

    Stop Smoking Cigarettes

    Treat An Overactive Bladder

    Others

    Key Market Players included in the report:

    Hisamitsu Pharmaceutical

    Novartis

    Johnson & Johnson

    Teikoku Pharma

    Mylan

    Actavis

    Mundipharma

    Henan Lingrui Pharmaceutical

    Changzhou Siyao

    Rfl Pharmaceutical

    Luye Pharma Group Ltd.

    Purdue Pharma L.P.

    Teva Pharmaceutical Industries Ltd.

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Transdermal Skin Patch Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Transdermal Skin Patch Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Transdermal Skin Patch Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Transdermal Skin Patch Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Transdermal Skin Patch Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Transdermal Skin Patch Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Transdermal Skin Patch sub-markets, depending on key regions (various vital states).
    To analyze Transdermal Skin Patch Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Transdermal Skin Patch Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Transdermal Skin Patch Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Transdermal Skin Patch Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Transdermal Skin Patch Market Overview
    

    3.1. Transdermal Skin Patch Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Transdermal Skin Patch Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Transdermal Skin Patch Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Fentanyl Transdermal Skin Patch
    

      4.4. Nicotine Transdermal Skin Patch
    

      4.5. Clonidine Transdermal Skin Patch
    

      4.6. Buprenorphine Transdermal Skin Patch5. Global Transdermal Skin Patch Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Transdermal Skin Patch Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Relieve Severe Pain
    

      5.4. Stop Smoking Cigarettes
    

      5.5. Treat An Overactive Bladder
    

      5.6. Others6. Global Transdermal Skin Patch Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Transdermal Skin Patch Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Transdermal Skin Patch Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Transdermal Skin Patch Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Transdermal Skin Patch Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Transdermal Skin Patch Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Transdermal Skin Patch Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Hisamitsu Pharmaceutical
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Novartis
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Johnson & Johnson
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Teikoku Pharma
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Mylan
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Actavis
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Mundipharma
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Henan Lingrui Pharmaceutical
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Changzhou Siyao
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. Rfl Pharmaceutical
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments  7.13. Luye Pharma Group Ltd.
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments  7.14. Purdue Pharma L.P.
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments  7.15. Teva Pharmaceutical Industries Ltd.
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.